Antagonism of Estrogen Receptor α-Driven Transcription Mediated by AP-1 in Breast Cancer Therapy

Antagonism of Estrogen Receptor α-Driven Transcription Mediated by AP-1 in Breast Cancer Therapy

The evolution of breast cancers results from the emergence of epithelial cell subpopulations containing variant Estrogen Receptor α which is able to bypass conventional treatments aimed at antagonizing the activity of this tumor-promoting receptor. The present investigation concerns a few estradiol...

Full description

Bibliographic Details
Main Author:	Guy Leclercq
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Endocrines
Subjects:	ligand conformation change temperature breast cancer endocrine therapy drug fluorination
Online Access:	https://www.mdpi.com/2673-396X/5/1/7

Similar Items

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
by: Léa Clusan, et al.
Published: (2023-04-01)

Genome-wide Estrogen Receptor-α activation is sustained, not cyclical
by: Andrew N Holding, et al.
Published: (2018-11-01)

The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells
by: Marco Fiocchetti, et al.
Published: (2021-09-01)

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
by: Esmael Besufikad Belachew, et al.
Published: (2021-05-01)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
by: Léa Clusan, et al.
Published: (2021-01-01)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
by: Ganesh V Raj, et al.
Published: (2017-08-01)

Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins
by: Jasmin Asberger, et al.
Published: (2020-12-01)

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox
by: Ke‐Da Yu, et al.
Published: (2021-10-01)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
by: Christina Panagiotis Malainou, et al.
Published: (2023-11-01)

New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
by: Jian Min, et al.
Published: (2024-03-01)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
by: Sarah A. Jeffreys, et al.
Published: (2020-09-01)

Hypoxia and ERα Transcriptional Crosstalk Is Associated with Endocrine Resistance in Breast Cancer
by: Charly Jehanno, et al.
Published: (2022-10-01)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
by: Tomás Reinert, et al.
Published: (2022-11-01)

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
by: Cristina Hernando, et al.
Published: (2021-07-01)

An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER<sup>+</sup>) Breast Cancer: Effects on Sensitive and Resistant Cell Lines
by: Cristina Amaral, et al.
Published: (2023-01-01)

Development of novel agents for the treatment of early estrogen receptor positive breast cancer
by: Mitchell J. Elliott, et al.
Published: (2022-03-01)

Stereoselectively fluorinated N-heterocycles: a brief survey
by: Xiang-Guo Hu, et al.
Published: (2013-11-01)

iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
by: María Inés Diaz Bessone, et al.
Published: (2019-12-01)

Editorial: Novel ligands and receptors in endocrine disorders
by: Huashan Zhao, et al.
Published: (2023-05-01)

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells
by: Gaetano Verde, et al.
Published: (2018-10-01)

Oophorectomy in Premenopausal Patients with Estrogen Receptor-Positive Breast Cancer: New Insights into Long-Term Effects
by: Fatima Khan, et al.
Published: (2023-02-01)

CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
by: Fiona H. Zhou, et al.
Published: (2023-03-01)

Editorial: Estrogen receptors in endocrine disorders
by: Tiziana Filardi, et al.
Published: (2023-11-01)

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling
by: Lindsay Angus, et al.
Published: (2023-09-01)

The Role of Progesterone Receptors in Breast Cancer
by: Li Z, et al.
Published: (2022-01-01)

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
by: Yubo Wang, et al.
Published: (2023-12-01)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
by: Jing Xu, et al.
Published: (2023-07-01)

Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
by: Niraj Neupane, et al.
Published: (2024-01-01)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
by: Giuseppe Bronte, et al.
Published: (2018-03-01)

Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
by: Yuxin Xie, et al.
Published: (2022-12-01)

Modulation of estrogen receptor α levels by endogenous and exogenous ligands
by: P. La Rosa, et al.
Published: (2011-01-01)

Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer
by: Kalevi Kairemo, et al.
Published: (2023-05-01)

μ2-Methanol-κ2O:O-bis[(1,10-phenanthroline-κ2N,N′)bis(2,3,4,5-tetrafluorobenzoato)-κO;κ2O,O′-copper(II)]
by: Junshan Sun
Published: (2019-11-01)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
by: Gu Ran, et al.
Published: (2012-05-01)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
by: David Rodriguez, et al.
Published: (2019-07-01)

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer
by: Sarah R. Hosford, et al.
Published: (2019-08-01)

Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions
by: Rohan Kalyan Rej, et al.
Published: (2024-01-01)

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
by: Amber J. Kiliti, et al.
Published: (2023-08-01)

Real World Experience of Long Term Treatment Outcome in Hormone Receptor-positive Metastatic Breast Cancer with or without Everolimus and Exemestane after Prior Aromatase Inhibitor
by: Thanate Dajsakdipon, et al.
Published: (2021-05-01)

Homologated amino acids with three vicinal fluorines positioned along the backbone: development of a stereoselective synthesis
by: Raju Cheerlavancha, et al.
Published: (2017-11-01)